by PEPID Newsroom | Mar 19, 2019 | Alerts
Tuesday, March 19, the FDA approved Zulresso (brexanolone) injection for intravenous (IV) use to treat post-partum depression (PPD) in adult women. No other drug before now has been approved to specifically treat PPD. Zulresso will be available through Risk Evaluation...
by PEPID Newsroom | Aug 3, 2018 | Emergency Medicine, Nursing, Pharmacy, Primary Care, Uncategorized
August kicks off with World Breastfeeding Week, now on its 27th year since it was first celebrated by the World Alliance for Breastfeeding Action (WABA) in 1992. Every August 1-7, WABA partners with a worldwide network of organizations to encourage breastfeeding,...
